RGL-193 / Shanghai Regenelead Therapies - LARVOL DELTA

An Open-label, Observational, Long-term Follow-up Study Evaluating the Safety and Efficacy of RGL-193 Putamen Injection in Patients With Primary Parkinson's Disease (clinicaltrials.gov) - P=N/A | N=6 | Not yet recruiting | Sponsor: Anhui Provincial Hospital

New trial • CNS Disorders • Movement Disorders • Parkinson's Disease

A Study on the Safety and Tolerability of RGL-193 in Patients With Advanced Parkinson's Disease (clinicaltrials.gov) - P1 | N=8 | Recruiting | Sponsor: Second Affiliated Hospital of Soochow University | Not yet recruiting ➔ Recruiting

Enrollment open • Metastases • CNS Disorders • Movement Disorders • Parkinson's Disease

A Study on the Safety and Tolerability of RGL-193 in Patients With Advanced Parkinson's Disease (clinicaltrials.gov) - P1 | N=8 | Not yet recruiting | Sponsor: Second Affiliated Hospital of Soochow University

Metastases • New P1 trial • CNS Disorders • Movement Disorders • Parkinson's Disease